Global Pharmaceutical Partnering Terms and Agreements Analysis Report 2010-2017
DUBLIN, September 11, 2017 /PRNewswire/ --
The "Global Pharmaceutical Partnering Terms and Agreements 2010-2017: Deal trends, players and financials" report has been added to Research and Markets' offering.
Global Pharmaceutical Partnering Terms and Agreements 2010 to 2017 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals. This report provides details of the latest Pharmaceutical agreements announced in the life sciences since 2010.
The report takes the reader through a comprehensive review Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Pharmaceutical partnering deals.
The report presents financial deal term values for Pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
The middle section of the report explores the leading dealmakers in the Pharmaceutical partnering field; both the leading deal values and most active Pharmaceutical dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.
One of the key highlights of the report is that over 8,000 online deal records of actual Pharmaceutical deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference.
Key benefits:
- In-depth understanding of Pharmaceutical deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Pharmaceutical agreements with real life case studies
- Detailed access to actual Pharmaceutical contracts entered into by leading biopharma companies
- Identify most active Pharmaceutical dealmakers since 2010
- Insight into terms included in a Pharmaceutical partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
The available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Pharmaceutical dealmaking
Chapter 3 - Leading Pharmaceutical deals
Chapter 4 - Most active Pharmaceutical dealmakers
Chapter 5 - Pharmaceutical contracts dealmaking directory
Chapter 6 - Pharmaceutical dealmaking by technology type
Chapter 7 - Partnering resource center
For more information about this report visit https://www.researchandmarkets.com/research/lf65zj/global
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article